In a crowded therapeutic landscape, establishing unmet need and articulating the value of new therapies is critical for payer decision-making.
We developed a Global Value Dossier synthesizing evidence across clinical, epidemiologic, humanistic, and economic domains.
Provided the foundation for payer engagement, supported conference presentations and peer-reviewed manuscripts, and continues to inform dissemination.